INS and type 2 diabetes mellitus: In 2005–2012, among patients who had any insulin use, only 31.4% had an hemoglobin A1c (HbA1c) < 7%; therefore, as glycemic control is still not attained by most people with diabetes, there is a need for new approaches to identify subgroups of people with diabetes (T1DM or T2DM) who might have risk factors that could impact treatment decisions and targeted disease management [12].